Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Virta Health Raises $65M Series D Round

2020-12-03
SAN FRANCISCO, CA, Virta Health, the first company dedicated to reversing type 2 diabetes without medications or surgery, has raised $65 million in Series D funding.
Led by Sequoia Capital Global Equities, the financing will support the growing demand for Virta's reversal treatments for type 2 diabetes and other chronic metabolic conditions.

The funding will be used to accelerate the company's investments in growth and scale its provider-led virtual care delivery platform, Continuous Remote Care, which is the backbone for Virta's transformative reversal therapies. Additionally, Virta will expand research and development of evidence-based, non-pharmaceutical therapies for other complex and costly metabolic conditions.

Alongside Sequoia Capital Global Equities, Caffeinated Capital participated in the round, which brings total funding to more than $230 million and values Virta Health at over $1.1 billion.

Virta Health provides the first treatment to safely and sustainably reverse type 2 diabetes without medications or surgery. Among enrolled patients in our clinical trial at one year, 60% achieved diabetes reversal and 94% of insulin users reduced or eliminated usage altogether. Results extend beyond diabetes reversal to other areas of metabolic and cardiovascular health, with sustained improvements in blood pressure, inflammation, liver function, and BMI. For enterprises, Virta puts 100% of its fees at risk and can reduce medical prescription costs by more than 70% in year 1 alone. Delivered through Virta's novel continuous remote care platform, the Virta Treatment provides unparalleled medical and behavioral support and is transforming the lives of people living with type 2 diabetes. To learn more, visit www.virtahealth.com, or follow us on Twitter and LinkedIn.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors